About Careers MedBlog Contact us

Rs.7 Diabetes Drug Boosts the Cost-Effectiveness of Pharma Market in India

by Reshma Anand on November 21, 2015 at 12:06 PM
Font : A-A+

Rs.7 Diabetes Drug Boosts the Cost-Effectiveness of Pharma Market in India

Anti-diabetic drug market has been potentially growing in India. As several drugs have been launched by various Indian pharmaceutical companies, Zydus Cadila has made a breakthrough in the diabetes drug market by launching its new drug at the most affordable cost.

Cadila has offered its drug Tenglyn, the generic version of oral anti-diabetic drug gliptins at a price of Rs. 7 per tablet in India. Gliptins have been ruling the diabetes market with its potential to induce insulin in the blood. Several pharma companies like Glenmark, Ajanta are already selling the same drug at a cost of Rs. 20 per tablet.


"With Tenglyn we provide patients suffering from diabetes access to this advanced treatment at the most affordable cost," said Sharvil Patel, Deputy Managing Director, Zydus Cadila.

Therefore, this new launch of the same drug at a cost of rs.7 will help 60 million diabetic patients economically. The cost-effective drug will also be made easily accessible all over the country. The price of Zydus is said to be one sixth of all other pharmaceutical companies.

Source: Medindia


Recommended Reading

Latest Diabetes News

Why Is Losing a Pancreatic Cell Contributing to Diabetes?
Type 2 diabetes mice injected with beta cells with increased CD63 protein marker production had their blood sugar levels restored to normal.
New Artificial Pancreas can Help Your Child with Diabetes: Here's How
Good news to children with diabetes: New artificial pancreas can help improve blood sugar control in kids.
Bright Lights, Big Risk: Alarming Link Between Light Exposure and Gestational Diabetes!
New study reveals the link between pre-sleep light exposure and gestational diabetes mellitus in pregnant women.
 Ease Diabetic Neuropathy Pain With Spinal Cord Stimulation
Spinal cord stimulation delivers electrical stimulation to the spinal cord to cut off pain signals to the brain and may ease pain associated with diabetic neuropathy.
How Digital Therapeutics Improve Blood Sugar Levels?
Cognitive behavioral therapy delivered via smartphone app was found to lower blood sugar levels in type 2 diabetes people.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Rs.7 Diabetes Drug Boosts the Cost-Effectiveness of Pharma Market in India Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests